These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 34526087)
141. Factors predicting prolonged empirical antifungal treatment in critically ill patients. Zein M; Parmentier-Decrucq E; Kalaoun A; Bouton O; Wallyn F; Baranzelli A; Elmanser D; Sendid B; Nseir S Ann Clin Microbiol Antimicrob; 2014 Mar; 13():11. PubMed ID: 24621182 [TBL] [Abstract][Full Text] [Related]
142. Prognostic Nutritional Index and CRP, age, platelet count, albumin level score in predicting mortality and intensive care unit admission for COVID-19. Bayram M; Yildirim O; S Ozmen R; Soylu B; Dundar AS; Koksal AR; Ekinci I; Akarsu M; Tabak O Biomark Med; 2021 Dec; 15(18):1733-1740. PubMed ID: 34784756 [TBL] [Abstract][Full Text] [Related]
143. COVID-19-Associated Pulmonary Aspergillosis (CAPA) in Northern Greece during 2020-2022: A Comparative Study According to the Main Consensus Criteria and Definitions. Siasios P; Arvaniti K; Zachrou E; Poulopoulou A; Pisanidou P; Vasileiadou G; Kaimakamis E; Georgopoulou A; Renta F; Lathyris D; Veroniki F; Geka E; Soultati I; Argiriadou E; Apostolidou E; Amoiridou P; Ioannou K; Kouras L; Mimitou I; Stokkos K; Flioni E; Pertsas E; Sileli M; Iasonidou C; Sourla E; Pitsiou G; Vyzantiadis TA J Fungi (Basel); 2023 Jan; 9(1):. PubMed ID: 36675902 [TBL] [Abstract][Full Text] [Related]
144. CT findings of COVID-19-associated pulmonary aspergillosis: a systematic review and individual patient data analysis. Hong W; White PL; Backx M; Gangneux JP; Reizine F; Koehler P; Bentvelsen RG; Cuestas ML; Fakhim H; Jung JI; Lee YK; Dalsania NR; Patti RK; Yoon SH Clin Imaging; 2022 Oct; 90():11-18. PubMed ID: 35908455 [TBL] [Abstract][Full Text] [Related]
152. COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses. Mead ME; de Castro PA; Steenwyk JL; Gangneux JP; Hoenigl M; Prattes J; Rautemaa-Richardson R; Guegan H; Moore CB; Lass-Flörl C; Reizine F; Valero C; Van Rhijn N; Bromley MJ; Rokas A; Goldman GH; Gago S; Microbiol Spectr; 2023 Mar; 11(2):e0512822. PubMed ID: 36946762 [TBL] [Abstract][Full Text] [Related]
153. Proven Aspergillus flavus pulmonary aspergillosis in a COVID-19 patient: A case report and review of the literature. Salehi M; Khajavirad N; Seifi A; Salahshour F; Jahanbin B; Kazemizadeh H; Hashemi SJ; Dehghan Manshadi SA; Kord M; Verweij PE; Khodavaisy S Mycoses; 2021 Aug; 64(8):809-816. PubMed ID: 33576014 [TBL] [Abstract][Full Text] [Related]
154. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. Maurer HC; Schult D; Koyumdzhieva P; Reitmeier S; Middelhoff M; Rasch S; List M; Janssen KP; Steiger K; Protzer U; Schmid RM; Neuhaus K; Haller D; Quante M; Lahmer T J Fungi (Basel); 2022 Nov; 8(12):. PubMed ID: 36547598 [TBL] [Abstract][Full Text] [Related]
155. COVID-19-Associated Pulmonary Aspergillosis in the Critical Care Setting. Livermore JM AACN Adv Crit Care; 2021 Dec; 32(4):398-403. PubMed ID: 34879133 [TBL] [Abstract][Full Text] [Related]
156. COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection. Lal PM; Arif A; Mohan A; Rackimuthu S; Hasan MM; Islam Z; Uday U; Wara UU; Shaikh MTA; Essar MY Clin Epidemiol Glob Health; 2022; 13():100960. PubMed ID: 35005301 [TBL] [Abstract][Full Text] [Related]
157. Invasive pulmonary aspergillosis in the intensive care unit: current challenges and best practices. Gaffney S; Kelly DM; Rameli PM; Kelleher E; Martin-Loeches I APMIS; 2023 Nov; 131(11):654-667. PubMed ID: 37022291 [TBL] [Abstract][Full Text] [Related]
158. A Case Series Demonstrating the Difficulties in Diagnosing COVID-19 Associated Pulmonary Aspergillus. Murali S; Jain H; Velepati S; Alvi M; Amzuta I Cureus; 2023 Jan; 15(1):e33802. PubMed ID: 36819356 [TBL] [Abstract][Full Text] [Related]
159. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis. Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT; J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744 [TBL] [Abstract][Full Text] [Related]
160. Invasive mould disease in fatal COVID-19: a systematic review of autopsies. Kula BE; Clancy CJ; Hong Nguyen M; Schwartz IS Lancet Microbe; 2021 Aug; 2(8):e405-e414. PubMed ID: 34189490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]